SBIR/STTR Research Award

Advanced Nucleation Technologies for Membrane Protein Crystallization to Accelerate Structure-Based Drug Design for Substance Use Disorders

Award identifier 0be83c54fad27d548fc24232a8452bde6ef235ba54a8ecfa3fb381b525ac2ae4Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$349,515

Program and phase

SBIR · Phase I

Award year

2018

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
DENOVX, LLC
Proposal award date
2018-07-01
Contract end date
2020-06-30
UEI
DDMLLCM3VAF8
Solicitation number
PA17-302
Topic code
NIDA

Research abstract

PROJECT SUMMARY The goal of this Phase I proposal is to improve membrane protein crystallization outcomes using bifunctionalhydrophilic hydrophobicself assembled monolayersSAMsas a substrate that interacts with the bicelle envelope and indirectly preconcentrates and preorganizes membrane proteins to facilitate nucleation and crystal growthOf thehuman membrane proteins potentially relevant to drug responsehave yet to be structurally characterized due in large part to challenges in crystallizationWith andgtof pharmaceuticals and other drugs targeting membrane proteinsproductivity improvements in protein crystallization that enable structural characterization will have a significant impact on Public HealthObtaining diffraction quality crystals is a key bottleneck in protein crystal structure determinationFunctional enhancements to crystallization surfaces can improve nucleation and crystallization outcomes for membrane proteinsTangible benefits including a more efficient use of the proteinincreased yield of crystalline materialand reduced times to crystallization onset will improve the understanding of signalling and responses for substances of abusepharmaceutical developmentand other areas of biomedical researchThe typical SAM will constitute a patterned bifunctional monolayer of chemically tunable end groups that indirectly facilitates preconcentration and preorganization of the membrane protein through interactions with the bicelle envelope surrounding the membrane proteinThis strategy preserves membrane protein solubility and conformation and acts to enhance preorganization and improves the propensity to achieve crystal nucleationThe hypothesis is that bifunctional SAMs interacting with a bicelle envelope will indirectly preconcentrate and preorganize membrane proteins to improve crystal nucleationSpecific AimCreatebifunctional SAMs of varying H bonding surface moietye gdonor acceptorhydrophilic hydrophobic balanceisland heightor island density and probe ability to facilitate targeted interactions with membrane protein bicelle envelopesCollect replicate datanon crystallization outcomesY Nvscontrol surfaces for bacteriorhodopsin bicelles using sitting drop vapor diffusionand advance top six performing bifunctional SAMs for quantitative assessment in AimSpecific AimFor select bifunctional SAMsdemonstrate statistically significantnimprovements ofin crystallization outcomeY Nimprovement in crystallization onset timeorincrease in quantity of protein crystals generated per trial vscontrols for bacteriorhodopsinConfirm X ray diffraction qualitye gby diffraction resolutionmosaicityetcof bacteriorhodopsin crystals produced on SAM surfacesPhase II will expand studies to other high value membrane protein targets that are recalcitrant to crystallizationDeNovX s innovative approaches to nucleation of membrane proteins will expand the structure function understanding in drug response and accelerate structure based design of new targets Project NarrativeRelevance to Public Health Research The role of structural biology in facilitating an understanding of biological function is well establishedand improvements in crystallization methods for membrane proteins are needed as this remains a key rate limiting step in the fieldAn acceleration in the acquisition of structural biology information will positively impact Public Health by expanding the structure function knowledge base for membrane proteinswhich will lead to a better understanding of drug action for both pharmaceuticals and substances of abuse

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

10 SBIR/STTR records share this UEI (2015–2024). Reported award amounts total $9,598,525. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.